As of August 21, 2026 6:35pm CDT, JNJ (Johnson & Johnson, XNYS) traded at $271.00, +1.87 (+0.69%) on the day (delayed quote). StockMarketLoop's Market Position model puts the current profit ratio at 90.69%, with support near $259.32 and resistance near $270.44. Market capitalization: $651.3B.

Source: StockMarketLoop real-time market data (massive-aggregates-fallback-5m). Not investment advice.

JNJ

Johnson & Johnson

XNYS · CS

$271.00 +0.69% Delayed market data
Volume4,642,523
Market cap$651.3B
Market position90.69%
Support / resistance$259.32 / $270.44

About Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenu

Explore JNJ

Open the interactive ticker terminal for charts, technical tools, market discussion and live modules.

Open JNJ ticker terminal
Observed August 21, 2026 6:35 pm CDT. Market data and model estimates only—not investment advice.
Stock Market LoopConnect. Learn. Share. Grow.
Stock Market Loop
Join StockmarketloopSign in to post, vote sentiment, save watchlists and view member tools.